GreyBird Ventures

North America, Massachusetts, United States, Concord

Description

GreyBird Ventures medical technology firm and invests in companies developing products for precision medicine.

Investor Profile

GreyBird Ventures has made 7 investments, with 1 in the past 12 months and 86% as lead.

Stage Focus

Series A (43%)
Series Unknown (29%)
Seed (14%)
Series C (14%)

Country Focus

United States (29%)
Germany (29%)
Israel (29%)
Austria (14%)

Industry Focus

Health Care
Health Diagnostics
Software
Biotechnology
Medical
Personal Health
Psychology
Compliance
Genetics
Information Technology

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does GreyBird Ventures frequently co-invest with?

Jumpspeed Ventures

Asia, Yerushalayim, Israel, Jerusalem

Co-Investments: 2

KfW

Europe, Hessen, Germany, Frankfurt

Co-Investments: 1

b2venture

Europe, Berlin, Germany, Berlin

Co-Investments: 1

OCCIDENT

Europe, Bayern, Germany, Munich

Co-Investments: 1

SHS Capital

Europe, Baden-Wurttemberg, Germany, Tübingen

Co-Investments: 1

Bosch Ventures

Europe, Baden-Wurttemberg, Germany, Stuttgart

Co-Investments: 1

Mey Capital Matrix

Europe, Bayern, Germany, München

Co-Investments: 1

Meron Capital

Asia, Tel Aviv, Israel, Tel Aviv

Co-Investments: 2

Sapir Venture Partners

Asia, Yerushalayim, Israel, Jerusalem

Co-Investments: 1

UVC Partners

Europe, Bayern, Germany, Garching

Co-Investments: 1

Which angels does GreyBird Ventures often collaborate with?

Michael Zeisser

North America, California, United States, San Francisco

Shared Deals: 1

Howard Morgan

North America, New York, United States, New York

Shared Deals: 1

What are some of recent deals done by GreyBird Ventures?

NeuroKaire

Tel Aviv-yafo, Tel Aviv, Israel

NeuoKaire develops a personalized medical testing tool to better treat depression.

Health CarePersonal HealthPsychology

Series UnknownDec 17, 2024

Amount Raised: $10,000,000

Genetika+

Tel Aviv-yafo, Tel Aviv, Israel

NeuoKaire develops a personalized medical testing tool to better treat depression.

Health CarePersonal HealthPsychology

Series ASep 30, 2021

Amount Raised: $10,000,000

Platomics

Vienna, Wien, Austria

The Industry Accelerator For In Vitro Diagnostics

ComplianceGeneticsHealth CareHealth DiagnosticsInformation TechnologySoftware

Series ASep 21, 2021

Amount Raised: $16,411,911

Angstrom Bio

Austin, Texas, United States

Angstrom Bio is biotechnology company that applies novel nucleotide chemistry and machine learning to the study

BiotechnologyHealth CareLife ScienceMedical

SeedJun 16, 2021

Amount Raised: $3,000,000

GNA Biosolutions

Munich, Bayern, Germany

GNA Biosolutions is a private molecular diagnostics company.

BiotechnologyHealth CareHealth DiagnosticsMedical

Series CAug 6, 2019

Amount Raised: $13,500,000

Atlas5D

Cambridge, Massachusetts, United States

Atlas5D is a leader in creating solutions to help people with reduced mobility live better and richer lives.

HardwareSoftware

Series AFeb 1, 2016

Amount Raised: $3,000,000

Hummingbird Diagnostics GmbH

Heidelberg, Baden-Wurttemberg, Germany

Its mission is to harness the power of blood bourne miRNAs to the immune system’s response to disease.

Health Care

Series UnknownJan 1, 2016

GreyBird Ventures

Description

Investor Profile

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does GreyBird Ventures frequently co-invest with?

Which angels does GreyBird Ventures often collaborate with?

What are some of recent deals done by GreyBird Ventures?

Ready to Raise Capital?

Pages

Free tools